Atara Biotherapeutics Inc

Research Atara Biotherapeutics Inc (ATRA) on Bullrun: market cap USD 100.64M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerATRA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 100.64M
• Financial periodFY2025
• RevenueUSD 120.77M
• Revenue growth-6.3%
• Net incomeUSD 32.69M
• Free cash flow-USD 50.94M

Valuation Snapshot

latest market cap is USD 100.64M.

About Atara Biotherapeutics Inc

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases.

Frequently asked questions

What is Atara Biotherapeutics Inc's market cap?

Atara Biotherapeutics Inc's market capitalization is USD 100.64M.

What does Atara Biotherapeutics Inc do?

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally.